AMERICAN JOURNAL OF GASTROENTEROLOGY, vol.103, no.11, pp.2776-2783, 2008 (SCI-Expanded)
OBJECTIVE: The efficacy and safety of entecavir in patients with chronic hepatitis B and advanced liver fibrosis/cirrhosis was assessed from three large, randomized, multicenter, phase III studies.